Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05630235 · ClinicalTrials.gov registry record · Phase 1

Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI

A Phase 1 study of Neuropathic Pain and SCI - Spinal Cord Injury, sponsored by University of Miami.

Recruiting
Registry status
Phase 1
Development phase
20
Enrollment target
1
Study location

NCT05630235 is a Phase 1 study of Neuropathic Pain and SCI - Spinal Cord Injury that is actively recruiting participants, run by University of Miami. The registered enrollment target is 20 participants, below the 101-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05630235, a Phase 1 study of Neuropathic Pain and SCI - Spinal Cord Injury, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
Phase 1
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The main purposes of this study are to (1) measure the effect of CBD/CBD-A on pain symptoms, pain intensity, pain unpleasantness, and skin sensitivity to hot and cold temperatures; and (2) measure the effect of CBD on brain electrical activity with electroencephalography (EEG).

Conditions Studied

Neuropathic Pain SCI - Spinal Cord Injury

Interventions

  • OTHER Placebo
  • DRUG CBD/CBD-A

Study Locations (1)

Florida

  • Lynn Rehabilitation Center - Miami

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-06-16
Est. Completion 2026-06-30
Phase Phase 1

Sponsor

University of Miami

721 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05630235

The ClinicalTrials.gov registry entry for NCT05630235 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 101-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (80% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Neuropathic Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05630235 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05630235 about?

NCT05630235 is a clinical study titled "Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI". The main purposes of this study are to (1) measure the effect of CBD/CBD-A on pain symptoms, pain intensity, pain unpleasantness, and skin sensitivity to hot and cold temperatures; and (2) measure the effect of CBD on brain electrical activity with electroencephalography (EEG).

What is the current status of trial NCT05630235?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2025-06-16. Estimated completion is 2026-06-30.

What conditions does trial NCT05630235 study?

This clinical trial studies the following conditions: Neuropathic Pain, SCI - Spinal Cord Injury.

What interventions are being tested in trial NCT05630235?

The interventions under investigation include: Placebo (OTHER), CBD/CBD-A (DRUG).

Who is sponsoring clinical trial NCT05630235?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05630235 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Neuropathic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Neuropathic Pain

All registered trials for this condition

SCI - Spinal Cord Injury

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.